share_log

HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

HC Wainwright & Co. 重申買入Cardiol Therapeutics,維持9美元的價格目標
Benzinga ·  06/14 06:05

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and maintains $9 price target.

HC Wainwright & Co.分析師Vernon Bernardino重申買進Cardiol Therapeutics(納斯達克:CRDL)並將目標股價維持在9美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論